Oxler Private Wealth LLC Eli Lilly & CO Transaction History

Oxler Private Wealth LLC

$254 Million
Q2 2024

A detailed history of Oxler Private Wealth LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Oxler Private Wealth LLC holds 6,022 shares of LLY stock, worth $5.33 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares

6,022

Previous 6,012 0.17%

Holding current value

$5.33 Million

Previous $4.68 Million 16.57%

% of portfolio

2.14%

Previous 1.92%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$724.87 - $909.04 $7,248 - $9,090	10 Added 0.17%	6,022 $5.45 Million
Q1 2024 Apr 24, 2024	BUY	$592.2 - $792.28 $2.44 Million - $3.26 Million	4,116 Added 217.09%	6,012 $4.68 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $2.15 Million - $2.53 Million	-4,090 Reduced 68.33%	1,896 $1.11 Million
Q3 2023 Oct 12, 2023	SELL	$434.7 - $599.3 $18,257 - $25,170	-42 Reduced 0.7%	5,986 $3.22 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $7,716 - $10,317	-22 Reduced 0.36%	6,028 $2.83 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $7,455 - $8,755	24 Added 0.4%	6,050 $2.08 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $321 - $374	1 Added 0.02%	6,026 $2.2 Million
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $4,447 - $5,068	15 Added 0.25%	6,025 $1.95 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $5,017 - $5,890	18 Added 0.3%	6,010 $1.95 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $30,040 - $37,332	-128 Reduced 2.09%	5,992 $1.72 Million
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $17,988 - $22,323	-80 Reduced 1.29%	6,120 $1.69 Million
Q1 2021 May 03, 2021	BUY	$164.32 - $212.72 $1.02 Million - $1.32 Million	6,200 New	6,200 $1.16 Million

Others Institutions Holding LLY

# of Institutions

3,870

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $841B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxler Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxler Private Wealth LLC with notifications on news.

Account

Oxler Private Wealth LLC Eli Lilly & CO Transaction History